3.6822
price down icon2.07%   -0.0778
after-market Dopo l'orario di chiusura: 3.68 -0.00218 -0.06%
loading
Precedente Chiudi:
$3.76
Aprire:
$3.76
Volume 24 ore:
22,322
Relative Volume:
1.75
Capitalizzazione di mercato:
$42.18M
Reddito:
$10.96M
Utile/perdita netta:
$-7.02M
Rapporto P/E:
-5.8447
EPS:
-0.63
Flusso di cassa netto:
$-3.72M
1 W Prestazione:
-4.41%
1M Prestazione:
-25.84%
6M Prestazione:
-37.38%
1 anno Prestazione:
-31.17%
Intervallo 1D:
Value
$3.65
$3.87
Intervallo di 1 settimana:
Value
$3.65
$4.00
Portata 52W:
Value
$3.65
$6.99

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name
Nome
Collplant Biotechnologies Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
73
Name
Cinguettio
@CollplantBio
Name
Prossima data di guadagno
2024-11-27
Name
Ultimi documenti SEC
Name
CLGN's Discussions on Twitter

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-02-17 Iniziato Alliance Global Partners Buy

Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie

pulisher
Oct 31, 2024

Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com

Oct 31, 2024
pulisher
Oct 25, 2024

EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN

Oct 25, 2024
pulisher
Oct 23, 2024

Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India

Oct 23, 2024
pulisher
Oct 21, 2024

Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 01, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 5.3% in September - MarketBeat

Oct 01, 2024
pulisher
Sep 27, 2024

Benjamin F. Edwards & Company Inc. Sells 10,690 Shares of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World

Sep 27, 2024
pulisher
Sep 25, 2024

CollPlant Shareholders Approve Key Proposals - TipRanks

Sep 25, 2024
pulisher
Sep 16, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest - MarketBeat

Sep 16, 2024
pulisher
Sep 02, 2024

CollPlant (CLGN), Stratasys Initiate Study for Breast Implants - MSN

Sep 02, 2024
pulisher
Aug 29, 2024

CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants - 3DPrint.com

Aug 29, 2024
pulisher
Aug 27, 2024

The Stratasys’ Origin® printer to be tested for CollPlant’s 3D-printed breast implants - 3d adept media

Aug 27, 2024
pulisher
Aug 26, 2024

HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN) - MarketBeat

Aug 26, 2024
pulisher
Aug 26, 2024

Head-To-Head Analysis: Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Aug 26, 2024
pulisher
Aug 26, 2024

HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.’s Q3 2024 Earnings (NASDAQ:CLGN) - Defense World

Aug 26, 2024
pulisher
Aug 23, 2024

FY2027 EPS Estimates for CollPlant Biotechnologies Ltd. Reduced by HC Wainwright (NASDAQ:CLGN) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World

Aug 23, 2024
pulisher
Aug 22, 2024

Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.

Aug 22, 2024
pulisher
Aug 22, 2024

CollPlant Schedules Shareholder Meeting - Investing.com India

Aug 22, 2024
pulisher
Aug 21, 2024

CollPlant Schedules Shareholder Meeting By Investing.com - Investing.com Australia

Aug 21, 2024
pulisher
Aug 21, 2024

Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies - Benzinga

Aug 21, 2024
pulisher
Aug 21, 2024

CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at HC Wainwright - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 21, 2024
pulisher
Aug 21, 2024

Earnings call: CollPlant Biotechnologies reports Q2 2024 financials By Investing.com - Investing.com Australia

Aug 21, 2024
pulisher
Aug 21, 2024

CollPlant Biotechnologies Ltd (CLGN) Q2 2024 Earnings Call Trans - GuruFocus.com

Aug 21, 2024
pulisher
Aug 20, 2024

Q2 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com

Aug 20, 2024
pulisher
Aug 20, 2024

CollPlant Announces Upcoming Shareholder Meeting - TipRanks

Aug 20, 2024
pulisher
Aug 20, 2024

Collplant stock hits 52-week low at $4.1 amid market challenges - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Even after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three years - Yahoo Finance

Aug 20, 2024
pulisher
Aug 20, 2024

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Nasdaq

Aug 20, 2024
pulisher
Aug 20, 2024

We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow - Simply Wall St

Aug 20, 2024
pulisher
Aug 19, 2024

CollPlant and Stratasys launch pre-clinical study for 3D implants - Investing.com India

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Earnings per Share (Dil - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Cash Flow for Lease Fin - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Market Cap : €48.54 Mil (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant and Stratasys announce pre-clinical study for regenerative breast implants - Med-Tech Innovation

Aug 19, 2024
pulisher
Aug 19, 2024

Stratasys and CollPlant commence pre-clinical study for 3D printed regenerative breast implants - TCT Magazine

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants - Lelezard

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Cash Flow from Financin - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Cash-to-Debt : 7.69 (As of Mar. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Machinery, Furniture, E - GuruFocus.com

Aug 19, 2024
pulisher
Aug 18, 2024

CLGN (CollPlant Biotechnologies) Debt-to-Revenue : 7.70 (As of Mar. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

CLGN (CollPlant Biotechnologies) EV-to-Revenue : 3.11 (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

CLGN (CollPlant Biotechnologies) 14-Day RSI : 48.58 (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Long-Term Debt & Capita - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Earnings Yield % : N/A% (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Accounts Receivable : €0.08 Mil (As of Mar. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Change In Receivables : €0.34 Mil (TTM As of Mar. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Inventory Turnover : 0.80 (As of Mar. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Free Cash Flow per Shar - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

CollPlant Biotechnologies (FRA:CPT) Preferred Stock : €0.00 Mil (As of Mar. 2024) - GuruFocus.com

Aug 17, 2024

Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Capitalizzazione:     |  Volume (24 ore):